Grand Angels sinks seed capital into ProNAi Therapeutics

Grand Angels is reaching across the Great Lakes State to plunk down some serious seed capital for one of Metro Detroit’s promising startups.

The Grand Rapids-based angel investor group has invested in ProNAi Therapeutics. The Plymouth-based biotech startup is developing a novel and proprietary DNAi drug technology platform to help fight cancer. It has enjoyed recent success with safely treating Non-Hodgkin’s Lymphoma patients in clinical trials.

The group has also invested in Ann Arbor-based Local Orbit, which is developing software that helps connect food producers (think farmers, co-ops and farmers markets) with grocers, restaurants and other eateries.

"Our applicants are roughly split between each side of the state," says Jody Vanderwel, president of Grand Angels. "We even have some from the northern part of the state."

Grand Angels launched a decade ago with the idea of focusing its investment on startups in the Grand Rapids area. Within a few years it expanded that focus to include the entire state of Michigan to enhance its deal flow. It started adding more members after making that decision, and now adds 3-4 new angel investors each year. The current membership stands at 48 high-net-worth individuals.

Source: Jody Vanderwel, president of Grand Angels
Writer: Jon Zemke

Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.

Related Company